title: Splanchnic and peripheral release of 3-methylhistidine in relation to its urinary excretion in human infection.
abstract: The present investigation was undertaken in order to determine the release of 3-methylhistidine (3MH) from the splanchnic region and from the leg, and the contributions these make to the increase in urinary 3MH excretion in infection. Thirteen febrile patients with infection were investigated. After an overnight fast, hepatic vein, femoral vein, and radial artery catheterizations were performed. Splanchnic and leg blood flows were determined by dye dilution technique. Plasma 3MH was analyzed by a modified HPLC method. The release of 3MH from the leg was 0.064 +/- 0.007 mumol/min (+/- SE) and from the splanchnic region 0.012 +/- 0.013 mumol/min. These releases of 3MH constitute 27% +/- 2% and 8% +/- 6% of the individual urinary excretions, respectively. With increasing degree of catabolism, measured as individual 3MH increase above baseline excretion or as the 3MH to creatinine ratio (3MH:Cr), the relative contribution to urinary excretion from the leg was increased (individual increase, P = 0.08; 3MH:Cr, P less than 0.01). Since this contribution was not decreased in the more catabolic patients, as would have been expected if the increase in urinary 3MH originated elsewhere, it is concluded that skeletal muscle is the source, and these results thus validate the use of urinary 3MH excretion as a marker of myofibrillar protein catabolism in infected patients.
authors.affiliation: Department of Infectious Diseases, University Hospital, Uppsala, Sweden.
authors.forename: J
authors.initials: J
authors.lastname: Sjölin
authors.forename: H
authors.initials: H
authors.lastname: Stjernström
authors.forename: S
authors.initials: S
authors.lastname: Henneberg
authors.forename: E
authors.initials: E
authors.lastname: Andersson
authors.forename: J
authors.initials: J
authors.lastname: Mårtensson
authors.forename: G
authors.initials: G
authors.lastname: Friman
authors.forename: J
authors.initials: J
authors.lastname: Larsson
mesh_terms: D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000097:blood / Q000378:metabolism* / Q000652:urine; D001783:Blood Flow Velocity; D005260:Female; D006639:Histidine / Q000031:analogs & derivatives*; D006801:Humans; D007866:Leg / Q000098:blood supply*; D008297:Male; D008762:Methylhistidines / Q000097:blood / Q000378:metabolism* / Q000652:urine; D008875:Middle Aged; D009124:Muscle Proteins / Q000378:metabolism; D013152:Splanchnic Circulation
chemical_list: D008762:Methylhistidines; D009124:Muscle Proteins; C028120:1-methylhistidine; D006639:Histidine; C028118:3-methylhistidine